Epigamia Sees $20 Million Secondary Deal Amid Ownership Shift

CONSUMER-PRODUCTS
Whalesbook Logo
AuthorVihaan Mehta|Published at:
Epigamia Sees $20 Million Secondary Deal Amid Ownership Shift

Dairy startup Epigamia has completed a $20 million secondary transaction, with existing backers Verlinvest and the Mirchandani family increasing their stakes. While the deal marks a significant change in the company's cap table, Epigamia remains a private firm not traded on stock exchanges.

Epigamia, the Indian dairy and snacking startup known for its Greek yogurt and protein-based products, has finalized a secondary transaction valued at over $20 million. In this deal, existing major investors—specifically Verlinvest and the family of the late founder Rohan Mirchandani—have increased their holdings in the company. The transaction also marked the entry of Sauce, an investment firm led by Manu Chandra, while early-stage investors DSG Consumer Partners and Ka Enterprises exited their positions.

Understanding the Secondary Deal

It is important for market observers to note that this was a secondary transaction, meaning shares were transferred between existing and incoming investors rather than the company raising new capital. Since Epigamia (Drums Food International) is a private company, its shares are not available for trading on the NSE or BSE. This type of deal often signals a transition as early investors exit and long-term backers consolidate their positions, reflecting confidence in the company's current stage of development.

Business Growth and Financial Goals

Epigamia has set ambitious targets for its future performance. The company aims to double its business operations every 24 to 30 months. Management expects to close the current financial year with an annual recurring revenue (ARR) of over ₹700 crore and has stated a longer-term goal of surpassing ₹1,000 crore in ARR by the 2028 financial year. The company describes itself as cash-rich and profitable, with no immediate plans to raise fresh capital to fund operations.

While Greek yogurt remains a primary revenue driver, contributing over half of the company's income, Epigamia has diversified its portfolio significantly. Recent expansions include protein milkshakes, smoothies, lactose-free products, and high-protein options like paneer. Strengthening the manufacturing backbone is a core part of the current strategy to support these growth targets.

Operational Risks and Sector Outlook

Operating in the perishable FMCG (Fast-Moving Consumer Goods) sector comes with inherent challenges. The company relies heavily on cold-chain management to ensure product quality and distribution efficiency. A significant portion of its sales—estimated between 47% and 48%—is derived from quick commerce channels. While this indicates strong alignment with modern urban consumer habits, it also creates a dependency on these platforms and the competitive pricing environment they operate in.

Investors looking at the broader dairy and snacking sector will watch how the company manages its ambitious expansion targets. The ability to maintain profitability while scaling production and navigating the competitive landscape will be key monitorables. Future updates to track include the company's progress toward its ARR milestones and any potential moves toward an eventual public listing, which is a common path for companies reaching this scale.

Disclaimer: This article is published for informational purposes only. This is not a buy sell recommendation.